Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
Hui ShiShuo SunHaoyue XuZongren ZhaoZhengzhong HanJun JiaDongmei WuJun LuHong-Mei LiuRutong YuPublished in: International journal of nanomedicine (2020)
The results demonstrate that the combination of TMZ and siPLK1 in A2PEC could enhance the efficacy of TMZ in treating glioma.